{"slideshow_credits": null, "snippet": "A lawsuit claimed that Cephalon, a subsidiary of Teva Pharmaceuticals, had paid generic manufacturers to keep a cheaper version of a drug off the market.", "abstract": "Teva Pharmaceutical Industries announces settlement of $512 million over claims by drug wholesalers and other companies that subsidiary Cephalon paid generic manufacturers to keep their cheaper versions of drug off market; settlement, largest ever paid to direct purchasers of drugs, must be approved by judge.", "section_name": "Business Day", "print_page": "6", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS"}, "web_url": "http://www.nytimes.com/2015/04/21/business/teva-to-pay-512-million-to-settle-suit-over-delay-of-sleep-disorder-drug.html", "lead_paragraph": "A lawsuit claimed that Cephalon, a subsidiary of Teva Pharmaceuticals, had paid generic manufacturers to keep a cheaper version of a drug off the market.", "headline": {"main": "Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug", "print_headline": "Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug"}, "_id": "5535a20c38f0d821accece45", "word_count": "572", "multimedia": [{"height": 126, "url": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/04/21/business/21SETTLE/21SETTLE-articleLarge.jpg", "legacy": {"xlarge": "images/2015/04/21/business/21SETTLE/21SETTLE-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-04-21T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Cephalon Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Generic Brands and Products", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Federal Trade Commission", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}